National Medical Products Administration
PulseAugur coverage of National Medical Products Administration — every cluster mentioning National Medical Products Administration across labs, papers, and developer communities, ranked by signal.
- 2026-05-13 regulatory China's drug regulator reported a record high in drug applications and approvals for 2025. source
3 day(s) with sentiment data
-
Hong Kong approves tax relief; Hengrui Medicine advances drug trials
Hong Kong's Legislative Council has approved a bill to implement tax relief measures, including one-time tax reductions and increased deductions, which will be reflected in taxpayers' assessments for the 2025/26 and 202…
-
Hengrui Medicine subsidiaries get drug trial approvals; Xiangcai merger review resumes
Hengrui Medicine announced that its subsidiaries have received approval from China's National Medical Products Administration for clinical trials of three drugs. These include SHR-3821 for advanced solid tumors, Adebeli…
-
China's drug regulator reports record applications and approvals for 2025
The National Medical Products Administration (NMPA) reported that in 2025, China saw a record high in both the number of drug applications submitted and those approved. The Center for Drug Evaluation received 20,149 dru…
-
Fengyuan Pharma's Vunorasan Fumarate approved; Haiou Co. clarifies data center business
Fengyuan Pharmaceutical's subsidiary, Bengbu Fengyuan Tushan Pharmaceutical, has received approval from China's National Medical Products Administration for its Vunorasan Fumarate chemical raw material. This drug is a p…
-
Xiamen Xiangyu to issue 10B yuan bonds; Beilu Pharma's contrast agent approved
Xiamen Xiangyu has received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than 10 billion yuan to professional investors. Separately, Beilu Pharmaceutical announced t…
-
China implements new import/export cosmetics rules, launches e-label pilot
China's General Administration of Customs has announced new regulations for imported and exported cosmetics, set to take effect on December 1st. In conjunction with the National Medical Products Administration, a pilot …
-
China's ChiNext Index Hits Record High Amidst Pharmaceutical Growth
The ChiNext index, a Chinese stock market index, has reached a new all-time high, surpassing its previous peak from 2015. This surge represents a significant increase in value over the past year. In other news, China's …
-
Henrui Medicine's HRS-3005 tablet receives approval for clinical trials in B-cell malignancies
Henrui Pharmaceutical has received approval from China's National Medical Products Administration to conduct clinical trials for its HRS-3005 tablets. This innovative anti-tumor drug, developed in-house, is intended for…
-
Taobao integrates AI try-on and Q&A for anniversary sale
Taobao has launched its "Answer and Get Free" event for its 510 anniversary, introducing a new AI-powered virtual try-on feature. The event allows users to participate by guessing numbers based on clues after searching …
-
China establishes national working group for intelligent medical device standardization
China's State Administration for Market Regulation has approved the establishment of a national standardization working group for intelligent medical devices. This group, managed by the National Medical Products Adminis…
-
AI health hardware firm Shanmu raises nearly $14M for continuous health monitoring
AI-native health hardware company Shanmu has secured nearly 100 million yuan in Series A funding, led by Shixi Capital and including participation from existing investors. The company plans to use these funds to launch …
-
China's AI medical device market shows growth in respiratory, eye, and orthopedic sectors
A new study analyzed regulatory data from China's National Medical Products Administration (NMPA) to identify trends in AI-enabled medical devices (AIMD). Researchers developed an automated method to screen over 4 milli…